Related by context. All words. (Click for frequent words.) 65 Afinitor 64 Taxotere ® 64 RG# [001] 63 T DM1 63 Sandostatin LAR 63 TMC# [001] 63 FTY# 62 vandetanib 62 ixabepilone 62 axitinib 61 QAB# 61 FOLFIRI 61 nab paclitaxel 61 panitumumab 61 Tarceva TM 61 Taxotere R 61 neratinib 61 satraplatin 61 INC# 61 sorafenib Nexavar 60 Rasilez Tekturna 60 telbivudine 60 glufosfamide 60 INCB# [001] 60 mapatumumab 60 ISENTRESS 60 bevacizumab Avastin 60 bevacizumab 60 docetaxel 60 Femara 60 low dose cytarabine 60 Gabapentin GR 60 Ixempra 60 sunitinib malate 60 temsirolimus 60 Imprime PGG 60 ZD# [001] 60 Vectibix 60 HGS ETR1 60 ASA# 60 pertuzumab 59 Tarceva 59 lapatinib Tykerb 59 CIMZIA TM 59 carboplatin paclitaxel 59 abiraterone acetate 59 TELCYTA 59 indacaterol 59 sorafenib tablets 59 Tarceva erlotinib 59 dasatinib 59 carboplatin 59 nilotinib 59 docetaxel chemotherapy 59 Fludara 59 Targretin 59 Tasigna 59 Aclasta 59 XGEVA 59 Hycamtin 59 OPAXIO 59 enzastaurin 59 valopicitabine 59 everolimus 59 Advexin 59 Sandostatin LAR Depot 58 BAY #-# 58 docetaxel Taxotere ® 58 Nexavar ® 58 Zolinza 58 Avastin bevacizumab 58 registrational trial 58 Vandetanib 58 Onbrez Breezhaler 58 GVAX 58 Exjade 58 Dapagliflozin 58 ZYBRESTAT 58 AZILECT R 58 ACTEMRA 58 REYATAZ R 58 cetuximab Erbitux 58 vorinostat 58 Sorafenib 58 vemurafenib 58 DU #b 58 HGS# 58 Diovan HCT 58 paclitaxel Taxol 58 Allovectin 7 ® 58 aflibercept 58 sorafenib 58 PXD# 58 temozolomide 58 phase IIb clinical 58 iniparib 58 vicriviroc 58 alvespimycin 58 lintuzumab 58 Genasense 58 GSK# [001] 58 cediranib 58 Doxil 58 dutasteride 58 Panzem R NCD 58 LEXIVA 58 YONDELIS 58 maximally tolerated dose 58 gefitinib Iressa 58 Nexavar 57 Halaven 57 ZACTIMA 57 huC# DM4 57 cetuximab Erbitux ® 57 AP# [003] 57 CIMZIA ™ 57 REMICADE ® 57 tocilizumab 57 topotecan 57 Gliadel Wafer 57 elotuzumab 57 HuMax CD4 57 forodesine 57 Gemcitabine 57 sunitinib 57 ZOLINZA 57 estramustine 57 BRIM2 57 zoledronic acid 57 pralatrexate 57 IRESSA 57 Abraxane 57 standard chemotherapy regimen 57 ACZ# 57 oral anticoagulant 57 AVASTIN 57 rosuvastatin calcium 57 Xinlay 57 HuMax EGFr 57 teriflunomide 57 SCH # 57 eltrombopag 57 vismodegib 57 AZD# 57 docetaxel Taxotere 57 NVA# 57 SUTENT 57 recurrent GBM 57 subcutaneous formulation 57 Afatinib 57 Herceptin trastuzumab 57 Amrubicin 57 FOLFOX 57 PROMACTA 57 lixisenatide 57 gemcitabine chemotherapy 57 Traficet EN 57 teduglutide 57 ipilimumab 57 FOLFOX4 57 pomalidomide 57 HER2 positive metastatic breast 57 LAF# 57 leucovorin 57 raltegravir 57 Dasatinib 57 pegylated liposomal doxorubicin 57 MAGE A3 ASCI 57 lapatinib 57 afatinib 57 VELCADE 57 gemcitabine 57 Dacogen injection 57 Xcytrin 57 Vidaza 57 ganetespib 57 docetaxel Taxotere R 57 Onrigin 57 interferon alfa 57 EOquin TM 56 PREZISTA r 56 ARIMIDEX 56 trastuzumab DM1 56 Taxotere 56 CR# vcMMAE 56 plus gemcitabine 56 SAR# [004] 56 μg dose 56 Gleevec Glivec 56 TORISEL 56 mg dose 56 rituximab 56 Tekamlo 56 Pazopanib 56 gemcitabine carboplatin 56 Bevacizumab 56 TG# [003] 56 TELINTRA 56 Emselex 56 dose cohorts 56 angiogenesis inhibitor 56 Panitumumab 56 decitabine 56 SEROQUEL XR 56 Aclasta Reclast 56 Clolar 56 biologic therapy 56 Pfizer Sutent 56 evaluating tivozanib 56 Erbitux cetuximab 56 Azixa 56 metaglidasen 56 Peg IFN 56 metastatic CRC 56 lasofoxifene 56 pegylated interferon alfa 2a 56 registrational studies 56 active comparator 56 Quinamed 56 Asentar 56 Phase #/#a trial 56 Aptivus ® 56 R sorafenib tablets 56 oblimersen 56 Vidaza R 56 PLX# 56 pemetrexed 56 XYOTAX 56 monotherapy 56 imatinib mesylate Gleevec 56 orBec 56 crizotinib PF # 56 EFAPROXYN 56 trabectedin 56 Junovan 56 oral ridaforolimus 56 TYKERB 56 ruxolitinib 56 Mipomersen 56 Laquinimod 56 YERVOY 56 fingolimod 56 LIALDA 56 telaprevir 56 motesanib 56 Cimzia TM 56 #D#C# 56 clodronate 56 KRN# 56 Irinotecan 56 Yondelis 56 Reolysin 56 anti TNF alpha 56 Exforge 56 Campath 56 ozarelix 56 HGS ETR2 56 Atrasentan 56 SIMPONI 56 amrubicin 56 sapacitabine 56 Tykerb 56 erlotinib Tarceva 56 OXi# 56 Camptosar ® 55 Afinitor ® 55 HUMIRA 55 laquinimod 55 infusional 5-FU/LV 55 paliperidone palmitate 55 Pemetrexed 55 Tarvacin 55 REOLYSIN ® 55 paclitaxel Taxol ® 55 LY# [003] 55 investigational compound 55 ERBITUX 55 Satraplatin 55 PEG Interferon lambda 55 paclitaxel 55 Aflibercept 55 lymphoma CTCL 55 Torisel 55 EOquin 55 XL# [003] 55 Bortezomib 55 RGB # 55 Pegintron 55 desvenlafaxine 55 peg IFN 55 Cetuximab Erbitux 55 Golimumab 55 Xeloda 55 Topotecan 55 Galvus 55 erlotinib Tarceva ® 55 Gemzar ® 55 adalimumab 55 BRAF inhibitor 55 Zoledronic acid 55 IL# PE#QQR 55 Erlotinib 55 tanespimycin 55 Ilaris 55 Tanespimycin 55 PEG SN# 55 Taspoglutide 55 APTIVUS 55 SELZENTRY 55 albinterferon alfa 2b 55 Azedra 55 trastuzumab Herceptin R 55 KAPIDEX 55 metastatic renal cell carcinoma 55 ELACYT 55 Taxotere docetaxel 55 Eli Lilly Gemzar 55 dacetuzumab 55 VELCADE melphalan 55 safinamide 55 zalutumumab 55 Xanafide 55 Zytiga 55 ProLindac 55 talactoferrin 55 metastatic castration resistant 55 SYMBICORT 55 PDE4 inhibitor 55 goserelin 55 Hycamtin ® 55 alfa 2a 55 Belinostat 55 gemcitabine cisplatin 55 XmAb# 55 OncoVEX GM CSF 55 Ceflatonin 55 Ceplene/IL-2 55 febuxostat 55 sitagliptin 55 Alkeran 55 Platinol ® cisplatin 55 FOLPI 55 ALGRX 55 ToGA 55 APTIVUS r 55 ibandronate 55 Allovectin 7 55 viral kinetic 55 Zometa 55 bevacizumab Avastin ® 55 CoFactor 55 letrozole Femara 55 dacarbazine 55 thymalfasin 55 bicalutamide 55 BYDUREON 55 TAXOTERE R 55 perifosine 55 pegylated interferon 55 peginterferon 55 romidepsin 55 PROSTVAC TM 55 sipuleucel T 55 LEUKINE 55 ORENCIA ® 55 Taxol paclitaxel 55 palonosetron 55 vinorelbine 55 lenalidomide 55 PEG INTRON 55 bazedoxifene 55 Tekturna HCT 55 oral deforolimus 55 lopinavir r 55 relapsed ovarian cancer 55 etanercept 55 IMC A# 55 plus prednisone 55 denosumab 55 Glivec 55 capecitabine Xeloda R 55 Safinamide 55 Erbitux 55 LEXIVA r 55 plus dexamethasone 55 placebo controlled clinical 55 bendamustine 55 Orazol 55 Mylotarg 54 recurrent NSCLC 54 TMC# [002] 54 Nexavar sorafenib 54 #mg/m# [001] 54 DOXIL 54 Phase IIIb clinical 54 fluoropyrimidine 54 ThermoDox R 54 BENLYSTA ® 54 FOLOTYN 54 Revlimid 54 Phase Ib clinical trials 54 Gleevec imatinib 54 Everolimus 54 TEMODAL 54 TYZEKA 54 FOLFIRINOX 54 pharmacokinetic PK 54 Rituxan MabThera 54 atrasentan 54 AEG# 54 cutaneous T cell 54 elagolix 54 Zactima 54 cetuximab 54 Vitaxin 54 paclitaxel carboplatin 54 VIDAZA 54 interferon gamma 1b 54 oral FTY# 54 Trastuzumab 54 MIRCERA 54 canakinumab 54 Reverset 54 Jevtana 54 Eribulin 54 raloxifene Evista 54 ARIKACE 54 randomized Phase III 54 odanacatib 54 proteasome inhibitor bortezomib 54 metastatic hormone refractory 54 azacitidine 54 abiraterone 54 tenofovir emtricitabine 54 Victoza ® 54 Roche Xeloda 54 sBLA 54 Campath alemtuzumab 54 pharmacokinetic PK study 54 posaconazole 54 GW# [003] 54 reslizumab 54 ritonavir boosted 54 trastuzumab 54 UPLYSO 54 IMA# 54 alemtuzumab Campath 54 Darunavir 54 anti TNF 54 ENBREL 54 Doxil ® 54 dose cohort 54 erlotinib 54 talabostat 54 mRCC 54 Aplidin R 54 Genasense ® 54 Fingolimod 54 evaluating satraplatin 54 aliskiren 54 SPRYCEL 54 Revlimid lenalidomide 54 volociximab 54 REMINYL ® 54 Xyotax 54 MabCampath 54 hA# 54 Gefitinib 54 TOCOSOL Paclitaxel 54 Seliciclib 54 irbesartan 54 Cladribine 54 dosing cohorts 54 Telaprevir 54 Exelon Patch 54 pemetrexed Alimta 54 Glufosfamide 54 Pertuzumab 54 PegIntron 54 Apaziquone 54 LymphoStat B 54 Lenalidomide 54 Omnitarg 54 Perifosine 54 Stalevo 54 Abiraterone acetate 54 Apixaban 54 ponatinib 54 Rituxan 54 alvimopan 54 ImClone Erbitux 54 gemcitabine Gemzar 54 Pirfenidone 54 tipranavir 54 Canvaxin 54 Bonefos 54 nitazoxanide 54 PTK ZK 54 INCB# [002] 54 DAVANAT 54 Cotara 54 Lapatinib 54 standard chemotherapy regimens 54 Arixtra 54 mcg kg 54 edoxaban 54 cilengitide 54 Daclizumab 54 ALIMTA 54 ASONEP 54 PEG Intron 54 CA4P 54 oral prodrug 54 refractory chronic lymphocytic 54 ruboxistaurin 54 Aptivus 54 marketed pegylated interferons 54 bosentan 54 fenofibric acid 54 Carboplatin 54 ADVEXIN 54 MAP# 54 regorafenib 54 ProSavin 54 Telcyta 54 RoACTEMRA 54 trastuzumab emtansine T DM1 54 randomized controlled Phase 54 Cimzia R 54 etravirine 54 relapsed SCLC 54 anti leukemic 54 Amplimexon 54 Exenatide 54 fosbretabulin 54 administered subcutaneously 54 deforolimus 54 TREANDA 54 INTELENCE 54 imatinib 54 GAMMAGARD 54 Ambrisentan 54 JANUVIA 54 RAPAFLO 54 Denosumab 53 Axitinib 53 phase IIb trial 53 REVLIMID ® 53 ADP receptor antagonist 53 imetelstat 53 liposomal doxorubicin 53 Votrient 53 5 fluorouracil leucovorin 53 dabigatran etexilate 53 Neurodex 53 placebo controlled Phase III 53 LymphoStat B TM 53 ELND# 53 Promacta 53 neoadjuvant 53 panitumumab Vectibix 53 Abatacept 53 MabThera 53 dosing cohort 53 mTOR inhibitor 53 Leukine 53 mertansine 53 Pixantrone 53 celgosivir 53 velafermin 53 rilpivirine 53 Sprycel 53 Avastin 53 efalizumab 53 Aromasin 53 chemotherapeutic regimen 53 concurrent chemoradiation 53 refractory CTCL 53 fallopian tube cancers 53 4mg/kg 53 brentuximab vedotin 53 prospectively defined 53 Carfilzomib 53 Boceprevir 53 roflumilast 53 Zebinix R 53 denufosol 53 elvitegravir 53 oral rivaroxaban 53 TRILIPIX 53 Lacosamide 53 HYCAMTIN 53 trabedersen 53 trastuzumab Herceptin 53 AVE# 53 Zevalin R Ibritumomab 53 Chemophase 53 SUTENT ® 53 phase Ib 53 MGd 53 Vinorelbine 53 Pegasys ® 53 TTF Therapy 53 Zevalin 53 Zalbin 53 MEK inhibitors 53 Voreloxin 53 cisplatin vinorelbine 53 Xelox 53 Protelos 53 rivaroxaban 53 Vfend 53 tipranavir r 53 IMGN# 53 Ixabepilone 53 cobicistat 53 Phase 2a trial 53 RAPTIVA 53 5-FU/LV 53 REVLIMID lenalidomide 53 APPRAISE 53 Keppra XR 53 RSR# 53 anti angiogenic therapy 53 gefitinib 53 PEGINTRON TM 53 Rasagiline 53 paclitaxel Taxol R 53 Gleevec 53 Alocrest 53 Revimmune 53 degarelix 53 briakinumab 53 COPEGUS 53 registrational 53 OMAPRO 53 Elitek 53 ACAPODENE 53 Dabigatran etexilate 53 MGCD# [001] 53 apremilast 53 melphalan prednisone 53 Actemra 53 daclizumab 53 IFN α 53 REVLIMID R 53 carfilzomib 53 PD LID 53 AMEVIVE 53 Temsirolimus 53 octreotide LAR 53 non squamous NSCLC 53 protein kinase inhibitor 53 Cloretazine 53 ularitide 53 ustekinumab 53 Eloxatin ® 53 dacarbazine chemotherapy 53 Multaq R 53 timolol 53 APTIVUS R 53 taspoglutide 53 perampanel 53 bortezomib Velcade 53 eribulin 53 dalbavancin 53 Stelara 53 receptor tyrosine kinase inhibitor 53 abatacept 53 generation purine nucleoside 53 MYDICAR ® 53 Treanda 53 nucleoside reverse transcriptase inhibitor 53 Caelyx 53 placebo controlled Phase 53 sunitinib Sutent 53 Rituxan rituximab 53 relapsing multiple sclerosis 53 SPIRIT IV 53 Rivaroxaban 53 unresectable stage 53 cetuximab Erbitux R 53 Xeloda capecitabine 53 fluvastatin 53 MyVax R 53 VPRIV 53 DEB# 53 PEGASYS ® 53 BRIM3 53 RANK Ligand inhibitor 53 Ophena TM 53 platinum refractory 53 HCD# [002] 53 Syncria 53 Delcath PHP System 53 ILLUMINATE 53 Randomized Phase 53 Viramidine 53 peginterferon alfa 2b 53 Prograf ® 53 confirmatory Phase III 53 Velcade 53 Octreolin 53 dose limiting toxicities 53 #mg BID [001] 53 bortezomib Velcade ® 53 FOLFOX regimen 53 telcagepant 53 Velcade bortezomib 53 PREOS 53 Orathecin 53 evaluating REVLIMID 53 S/GSK# 53 fenofibrate 53 IRX 2 53 ZEVALIN 52 trastuzumab DM1 T DM1 52 cisplatin chemotherapy 52 Civacir 52 CHOP chemotherapy 52 BEXXAR 52 Pralatrexate 52 Tamibarotene 52 CAELYX 52 Anti TNF 52 Onco TCS 52 GetGoal Phase III 52 Liraglutide 52 pazopanib 52 FUZEON 52 RITUXAN 52 PRISTIQ 52 PS# [001] 52 olaparib 52 PSMA ADC 52 integrase inhibitor 52 Kepivance 52 Teriflunomide 52 median PFS 52 ambrisentan 52 Neulasta ® 52 Leukine ® 52 IMiDs 52 Docetaxel 52 Proxinium TM 52 AZILECT 52 milatuzumab 52 mometasone furoate 52 dosage regimens 52 TLK# 52 pegylated interferon alpha 2a 52 insulin degludec 52 Epratuzumab 52 picoplatin 52 Betaferon ® 52 tolvaptan 52 Cethrin 52 adalimumab Humira 52 pancreatic neuroendocrine tumors 52 mometasone 52 GRN#L 52 Sym# 52 HuLuc# 52 mitoxantrone 52 Viread Emtriva 52 palifermin 52 Phenoptin 52 rosuvastatin 52 phase IIa clinical 52 EndoTAG TM -1 52 Elotuzumab 52 gadobutrol 52 alefacept 52 CANCIDAS 52 KOMBIGLYZE XR 52 PrevOnco ™ 52 Thalomid ® 52 darunavir 52 Paclitaxel 52 Allovectin 7 R 52 ELIQUIS 52 FOLFOX6 chemotherapy regimen 52 Metformin GR 52 Folotyn 52 almorexant 52 Neuvenge 52 TASKi2 52 diabetic neuropathic pain 52 Campath ® 52 huN# DM1 52 peginterferon alfa 2a Pegasys 52 atazanavir 52 calcitonin 52 androgen independent 52 Oxaliplatin 52 BEMA TM Fentanyl 52 letrozole 52 farletuzumab 52 recurrent glioblastoma 52 ABRAXANE 52 achieved ACR# 52 plus DOXIL 52 BZL# 52 galiximab 52 CCX# 52 etoposide 52 Vimpat ® 52 CBLC# 52 ZYBRESTAT fosbretabulin 52 HBeAg positive patients 52 rapid virologic response 52 PREZISTA 52 ticagrelor 52 Arikace 52 BR.# 52 lurasidone 52 Ocrelizumab 52 favorable pharmacokinetic profile 52 amifostine 52 vidofludimus 52 Darusentan 52 pain palliation 52 mg BID 52 arzoxifene 52 R#/MEM # 52 ADVEXIN clinical 52 ACTEMRA TM 52 Bezielle 52 eniluracil 52 CDP# 52 ongoing Phase 1b 52 sargramostim 52 RP# [002] 52 Aplidin 52 5FU 52 WelChol 52 Novartis Afinitor 52 rindopepimut 52 dacarbazine DTIC 52 fulvestrant 52 seliciclib 52 entecavir 52 INTEGRILIN 52 fluorouracil 52 Targretin capsules 52 Tyrima 52 etanercept Enbrel 52 dasatinib Sprycel ® 52 Archexin 52 anastrozole 52 boosted protease inhibitor 52 TACI Ig 52 Rasilamlo 52 antitumor activity 52 Raptiva R 52 Xolair 52 custirsen 52 pegylated interferon alfa 2b 52 gastrointestinal stromal tumors 52 paliperidone ER 52 Genentech Herceptin 52 anticancer therapy 52 Panzem NCD 52 sorafenib Nexavar ® 52 metastatic castrate resistant 52 cabazitaxel 52 QNEXA 52 Ceplene 52 Marqibo 52 multicenter Phase II 52 CYT# 52 hormone refractory metastatic prostate 52 CUSTOM III 52 Emend 52 brentuximab vedotin SGN 52 non squamous 52 phase IIb 52 Interferon beta 1a 52 EGFR TKI 52 Panzem 52 Rasilez 52 Maraviroc 52 romiplostim 52 AQ4N 52 riociguat 52 Folfox 52 dosing intervals 52 Phase #b/#a clinical 52 gemcitabine Gemzar ® 52 AZILECT ® 52 Trexima 52 chronic angina 52 atacicept 52 ULORIC 52 XL# XL# XL# 52 Advagraf 52 aleglitazar 52 Hepatocellular Carcinoma HCC 52 cisplatin 52 nilotinib Tasigna 52 ZK EPO 52 mg kg dose 52 L MTP PE 52 Pixuvri 52 CLARITY study 52 IXEMPRA 52 cyclophosphamide chemotherapy 52 TNF inhibitor 52 ABRAXANE ® 52 Vidaza azacitidine 52 Paraplatin ® 52 bosutinib 52 tremelimumab 52 pharmacodynamic PD 52 Nimotuzumab 52 nucleoside analog 52 APOPTONE 52 mycophenolate mofetil 52 TNF alpha inhibitor 52 VAPRISOL 52 Phase Ib study 52 rilonacept 52 PF # [001] 52 TAXUS Liberte Stent 52 depsipeptide 52 investigational oral 52 Zybrestat 52 Romidepsin 52 TRISENOX 52 RDEA# 52 Raptiva ® 52 surrogate endpoint 52 SUCCEED trial 52 toremifene 52 samalizumab 52 Sutent 52 Zenvia Phase III 52 AEGR 52 Technosphere Insulin 52 Degarelix 52 prGCD 52 ritonavir 52 anakinra 52 regadenoson 52 Durezol 52 liposomal formulation 52 tubulin inhibitor 52 #mg/m# [002] 52 ISIS # 52 oral cladribine 52 SERMs 52 taxane chemotherapy 52 RE LY 52 Lenocta 52 pitavastatin 51 phase IIa 51 Phase 1b 51 Xgeva 51 SPIRIVA HandiHaler 51 LEP ETU 51 Sorafenib Nexavar 51 Navelbine ® 51 QVA# 51 dose regimens 51 Combidex 51 eribulin mesylate 51 motavizumab 51 mg doses 51 GALNS 51 non metastatic osteosarcoma 51 SinuNase 51 evaluable patients 51 SCCHN 51 FOLFOX6 51 lenalidomide dexamethasone 51 anti EGFR antibody 51 ZADAXIN 51 tasocitinib 51 alogliptin 51 Cimzia 51 paclitaxel chemotherapy 51 ridaforolimus 51 Rexin G 51 Eculizumab 51 Phase 2b clinical 51 Copegus 51 Clevudine 51 exemestane Aromasin 51 ascending dose 51 FASLODEX 51 liraglutide 51 HuMax CD# 51 Alpharadin 51 ticagrelor Brilinta 51 omalizumab 51 MoxDuo IR 51 SVR# 51 Increlex ® 51 thalidomide Thalomid